Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Avricore Health Inc V.AVCR

Alternate Symbol(s):  AVCRF

Healthcare Diagnostics & Research
Avricore Health Inc. is a pharmacy service innovator focused on acquiring and developing early-stage technologies aimed at advancing pharmacy practice and patient care. The Company is involved in the business of health data and point-of-care technologies (POCT). HealthTab, its flagship offering, is a turnkey point-of-care testing solution that combines point-of-care technologies with a secure... see more

Recent & Breaking News (TSXV:AVCR)

VANC Pharmaceuticals Receives Health Canada Class-III Approval for Ferrous Fumarate Products

GlobeNewswire September 8, 2017

VANC Receives Recommendation from Glass Lewis

GlobeNewswire September 7, 2017

VANC Pharmaceuticals Announces Provincial Formulary Approvals for Atlantic Canada

GlobeNewswire September 6, 2017

VANC Pharmaceuticals Receives Updated Health Canada Approval for Hema-Fer with New Indication for Use in Pregnancy

GlobeNewswire August 24, 2017

VANC Delivers Proxy Circular

GlobeNewswire August 22, 2017

VANC Pharmaceuticals Appoints Mr. Sherif Guorgui To Board of Directors

GlobeNewswire August 15, 2017

VANC Pharmaceuticals Closed First Tranche of Non Brokered Private Placement

GlobeNewswire August 4, 2017

VANC Pharmaceuticals Provides Corporate Update

GlobeNewswire August 1, 2017

VANC Pharmaceuticals Announces Hiring of Director of Pharmacy Solutions

GlobeNewswire July 24, 2017

VANC Pharmaceuticals Announces Non Brokered Private Placement

GlobeNewswire July 20, 2017

VANC Files Notice of Civil Claim Against Mo Aziz and Canagen

GlobeNewswire July 19, 2017

VANC Pharmaceuticals Announces Financing and Corporate Update

MarketWire Canada June 28, 2017

VANC Responds to Baseless Letter and Defamatory Comments by Mo Aziz and Canagen

MarketWire Canada June 15, 2017

VANC Pharmaceuticals Achieves Listing of 17 Generic Products with National Distributor

MarketWire Canada June 1, 2017

VANC Pharmaceuticals Announces Canadian Distribution Agreement for INSTI® HIV-1/HIV-2 Antibody Test

MarketWire Canada May 17, 2017

VANC Pharmaceuticals Appointment of Mr. Alan Arnstein to its Board of Directors

MarketWire Canada April 20, 2017

VANC Pharmaceuticals Provides Marketing Update

MarketWire Canada March 24, 2017

VANC Pharmaceuticals Launches New OTC Laxative Product Sennace

MarketWire Canada February 27, 2017

VANC Pharmaceuticals Provides Corporate Update

MarketWire Canada February 7, 2017

VANC Pharmaceuticals Provides Corporate Update

Marketwired January 31, 2017